Education
About Us
Working with TipRanks
Follow Us
Clinical Laserthermia Systems AB Class B (SE:CLS.B)
:CLS.B
RESEARCH TOOLSreports
CLS.B Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr2.43 - kr22.63
Previous CloseN/A
Volume24.29K
Average Volume (3M)71.43K
Market Cap
€58.08M
Enterprise ValueN/A
Total Cash (Recent Filing)€22.51M
Total Debt (Recent Filing)kr224.00K
Price to Earnings (P/E)―
Beta1.35
Next Earnings
May 16, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.06
Shares Outstanding20,163,593
10 Day Avg. Volume67,038
30 Day Avg. Volume71,428
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.83
Price to Sales (P/S)0.00
P/FCF Ratio-1.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
CLS.B FAQ
What was Clinical Laserthermia Systems AB Class B’s price range in the past 12 months?
Clinical Laserthermia Systems AB Class B lowest stock price was kr2.43 and its highest was kr22.63 in the past 12 months.
What is Clinical Laserthermia Systems AB Class B’s market cap?
Clinical Laserthermia Systems AB Class B’s market cap is €58.08M.
When is Clinical Laserthermia Systems AB Class B’s upcoming earnings report date?
Clinical Laserthermia Systems AB Class B’s upcoming earnings report date is May 16, 2025 which is today.
How were Clinical Laserthermia Systems AB Class B’s earnings last quarter?
Clinical Laserthermia Systems AB Class B released its earnings results on Feb 21, 2025. The company reported -kr0.43 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.43.
Is Clinical Laserthermia Systems AB Class B overvalued?
According to Wall Street analysts Clinical Laserthermia Systems AB Class B’s price is currently Overvalued.
Does Clinical Laserthermia Systems AB Class B pay dividends?
Clinical Laserthermia Systems AB Class B does not currently pay dividends.
What is Clinical Laserthermia Systems AB Class B’s EPS estimate?
Clinical Laserthermia Systems AB Class B’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clinical Laserthermia Systems AB Class B have?
Clinical Laserthermia Systems AB Class B has 20,163,593 shares outstanding.
What happened to Clinical Laserthermia Systems AB Class B’s price movement after its last earnings report?
Clinical Laserthermia Systems AB Class B reported an EPS of -kr0.43 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.618%.
Which hedge fund is a major shareholder of Clinical Laserthermia Systems AB Class B?
Currently, no hedge funds are holding shares in SE:CLS.B
---
Company Description
Clinical Laserthermia Systems AB Class B
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
---
Technical Analysis
S2Medical AB Class B
―
Qlife Holding AB
―
SpectraCure AB
―
AegirBio AB
―
Luxbright AB
―
---